Ipilimumab with and without Nivolumab in Patients with Classic Hodgkin Lymphoma with Progression after PD-1 Blockade

被引：0

作者：

Merryman, Reid W. ^{[1
]}

Kline, Justin ^{[2
]}

Redd, Robert A. ^{[3
]}

Welsh, Emma L. ^{[4
]}

Pfaff, Kathleen ^{[4
]}

Lee, Hannah Juhaie ^{[1
]}

Mcdonough, Mikaela M. ^{[5
]}

Ahn, Inhye E. ^{[1
]}

Brown, Jennifer R. ^{[6
]}

Crombie, Jennifer L. ^{[1
]}

Davids, Matthew S. ^{[1
]}

Fisher, David C. ^{[1
]}

Jacobsen, Eric D. ^{[7
]}

Jacobson, Caron A. ^{[1
]}

Kim, Austin I. ^{[1
,5
]}

Odejide, Oreofe O. ^{[1
]}

Parry, Erin M. ^{[1
]}

Ryan, Christine E. ^{[1
]}

Shipp, Margaret A. ^{[1
]}

Armand, Philippe ^{[1
]}

Rodig, Scott J. ^{[4
]}

Abramson, Jeremy S. ^{[8
]}

Lacasce, Ann S. ^{[1
]}

机构：

[1] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA

[2] Univ Chicago Med, Dept Med, Sect Hematol Oncol, Chicago, IL USA

[3] Dana Farber Canc Inst, Dept Data Sci, Boston, MA USA

[4] Brigham & Womens Hosp, Dept Pathol, Boston, MA USA

[5] Dana Farber Canc Inst, Boston, MA USA

[6] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA USA

[7] Dana Farber Canc Inst, Boston, MA USA

[8] Massachusetts Gen Hosp, Canc Ctr, Boston, MA USA

来源：

BLOOD | 2024年 / 144卷

关键词：

D O I：

10.1182/blood-2024-203414

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1669 / 1670

页数：2

共 50 条

[1] Allogeneic transplantation after PD-1 blockade for classic Hodgkin lymphoma
Merryman, Reid W.
Castagna, Luca
Giordano, Laura
Ho, Vincent T.
Corradini, Paolo
Guidetti, Anna
Casadei, Beatrice
Bond, David A.
Jaglowski, Samantha
Spinner, Michael A.
Arai, Sally
Lowsky, Robert
Shah, Gunjan L.
Perales, Miguel-Angel
De Colella, Jean Marc Schiano
Blaise, Didier
Herrera, Alex F.
Shouse, Geoffrey
Spilleboudt, Chloe
Ansell, Stephen M.
Nieto, Yago
Badar, Talha
Hamadani, Mehdi
Feldman, Tatyana A.
Dahncke, Lori
Singh, Anurag K.
McGuirk, Joseph P.
Nishihori, Taiga
Chavez, Julio
Serritella, Anthony V.
Kline, Justin
Mohty, Mohamad
Dulery, Remy
Stamatoulas, Aspasia
Houot, Roch
Manson, Guillaume
Moles-Moreau, Marie-Pierre
Orvain, Corentin
Bouabdallah, Kamal
Modi, Dipenkumar
Ramchandren, Radhakrishnan
Lekakis, Lazaros
Beitinjaneh, Amer
Frigault, Matthew J.
Chen, Yi-Bin
Lynch, Ryan C.
Smith, Stephen D.
Rao, Uttam
Byrne, Michael
Romancik, Jason T.
LEUKEMIA, 2021, 35 (09) : 2672 - 2683
[2] Allogeneic transplantation after PD-1 blockade for classic Hodgkin lymphoma
Reid W. Merryman
Luca Castagna
Laura Giordano
Vincent T. Ho
Paolo Corradini
Anna Guidetti
Beatrice Casadei
David A. Bond
Samantha Jaglowski
Michael A. Spinner
Sally Arai
Robert Lowsky
Gunjan L. Shah
Miguel-Angel Perales
Jean Marc Schiano De Colella
Didier Blaise
Alex F. Herrera
Geoffrey Shouse
Chloe Spilleboudt
Stephen M. Ansell
Yago Nieto
Talha Badar
Mehdi Hamadani
Tatyana A. Feldman
Lori Dahncke
Anurag K. Singh
Joseph P. McGuirk
Taiga Nishihori
Julio Chavez
Anthony V. Serritella
Justin Kline
Mohamad Mohty
Remy Dulery
Aspasia Stamatoulas
Roch Houot
Guillaume Manson
Marie-Pierre Moles-Moreau
Corentin Orvain
Kamal Bouabdallah
Dipenkumar Modi
Radhakrishnan Ramchandren
Lazaros Lekakis
Amer Beitinjaneh
Matthew J. Frigault
Yi-Bin Chen
Ryan C. Lynch
Stephen D. Smith
Uttam Rao
Michael Byrne
Jason T. Romancik
Leukemia, 2021, 35 : 2672 - 2683
[3] PD-1 Blockade in Classic Hodgkin Lymphoma comment
Ansell, Stephen M.
JCO ONCOLOGY PRACTICE, 2021, 17 (02) : 72 - +
[4] PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
Ansell, Stephen M.
Lesokhin, Alexander M.
Borrello, Ivan
Halwani, Ahmad
Scott, Emma C.
Gutierrez, Martin
Schuster, Stephen J.
Millenson, Michael M.
Cattry, Deepika
Freeman, Gordon J.
Rodig, Scott J.
Chapuy, Bjoern
Ligon, Azra H.
Zhu, Lili
Grosso, Joseph F.
Kim, Su Young
Timmerman, John M.
Shipp, Margaret A.
Armand, Philippe
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (04): : 311 - 319
[5] PD-1 blockade for untreated Hodgkin lymphoma
Moskowitz, Alison J.
BLOOD, 2021, 137 (10) : 1271 - 1272
[6] The Combination of Nivolumab and CC-486 Is Active in Hodgkin Lymphoma Refractory to PD-1 Blockade
Mei, Matthew G.
Chen, Lu
Puverel, Sandrine
Budde, L. Elizabeth
Kambhampati, Swetha
Daniels, Shari
Dunning, Bev
Banez, Melissa
Kwak, Larry W.
Herrera, Alex F.
BLOOD, 2023, 142
[7] PD-1 Blockade After Avelumab in Relapsed/Refractory Classical Hodgkin Lymphoma
Thiruvengadam, Swetha Kambhampati
Mei, Matthew G.
Godfrey, James
Siddiqi, Tanya
Salhotra, Amandeep
Chen, Robert
Smith, Eileen
Popplewell, Leslie L.
Herrera, Alex F.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 (10): : E893 - E897
[8] PD-1/PD-L1 Pathway and Its Blockade in Patients with Classic Hodgkin Lymphoma and Non-Hodgkin Large-Cell Lymphomas
Xie, Wei
Medeiros, L. Jeffrey
Li, Shaoying
Yin, C. Cameron
Khoury, Joseph D.
Xu, Jie
CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2020, 15 (04) : 372 - 381
[9] PD-1/PD-L1 Pathway and Its Blockade in Patients with Classic Hodgkin Lymphoma and Non-Hodgkin Large-Cell Lymphomas
Wei Xie
L. Jeffrey Medeiros
Shaoying Li
C. Cameron Yin
Joseph D. Khoury
Jie Xu
Current Hematologic Malignancy Reports, 2020, 15 : 372 - 381
[10] Ipilimumab with or without nivolumab in PD-1 or PD-L1 blockade refractory metastatic melanoma: a randomized phase 2 trial
Ari VanderWalde
Shay L. Bellasea
Kari L. Kendra
Nikhil I. Khushalani
Katie M. Campbell
Philip O. Scumpia
Lawrence F. Kuklinski
Frances Collichio
Jeffrey A. Sosman
Alexandra Ikeguchi
Adrienne I. Victor
Thach-Giao Truong
Bartosz Chmielowski
David C. Portnoy
Yuanbin Chen
Kim Margolin
Charles Bane
Constantin A. Dasanu
Douglas B. Johnson
Zeynep Eroglu
Sunandana Chandra
Egmidio Medina
Cynthia R. Gonzalez
Ignacio Baselga-Carretero
Agustin Vega-Crespo
Ivan Perez Garcilazo
Elad Sharon
Siwen Hu-Lieskovan
Sapna P. Patel
Kenneth F. Grossmann
James Moon
Michael C. Wu
Antoni Ribas
Nature Medicine, 2023, 29 : 2278 - 2285

← 1 2 3 4 5 →